Encompass Health Corp (EHC) Shares Sold by Garrison Bradford & Associates Inc.

Garrison Bradford & Associates Inc. lowered its holdings in shares of Encompass Health Corp (AMEX:EHC) by 3.5% in the third quarter, HoldingsChannel.com reports. The firm owned 27,608 shares of the company’s stock after selling 996 shares during the period. Encompass Health makes up 1.7% of Garrison Bradford & Associates Inc.’s portfolio, making the stock its 16th largest position. Garrison Bradford & Associates Inc.’s holdings in Encompass Health were worth $2,152,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the stock. Harvest Fund Management Co. Ltd acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $107,000. IFP Advisors Inc raised its position in shares of Encompass Health by 696.3% in the third quarter. IFP Advisors Inc now owns 1,521 shares of the company’s stock valued at $119,000 after buying an additional 1,330 shares in the last quarter. Bridgeworth LLC acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $127,000. Meeder Asset Management Inc. raised its position in shares of Encompass Health by 97.0% in the second quarter. Meeder Asset Management Inc. now owns 2,092 shares of the company’s stock valued at $142,000 after buying an additional 1,030 shares in the last quarter. Finally, Rehmann Capital Advisory Group raised its position in shares of Encompass Health by 108.3% in the second quarter. Rehmann Capital Advisory Group now owns 2,233 shares of the company’s stock valued at $151,000 after buying an additional 1,161 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

In other Encompass Health news, insider Andrew L. Price sold 9,457 shares of the business’s stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $80.04, for a total transaction of $756,938.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by insiders.

A number of research firms have recently weighed in on EHC. Zacks Investment Research upgraded shares of Encompass Health from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a research report on Wednesday, October 31st. Piper Jaffray Companies upgraded shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Credit Suisse Group lifted their price target on shares of Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. Mizuho reiterated a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a research report on Thursday, July 26th. Finally, SunTrust Banks reiterated a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a research report on Friday, July 20th. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $70.30.

Shares of EHC opened at $57.67 on Monday. Encompass Health Corp has a one year low of $40.86 and a one year high of $59.29.

Encompass Health (AMEX:EHC) last announced its quarterly earnings data on Monday, October 29th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.79 by $0.12. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. The business’s quarterly revenue was up 8.8% compared to the same quarter last year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 15th. Shareholders of record on Wednesday, January 2nd will be given a dividend of $0.27 per share. The ex-dividend date is Monday, December 31st. This represents a $1.08 annualized dividend and a yield of 1.87%.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

See Also: Cost of Debt

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply